文献速递角膜与眼表疾病青光眼

前房接种建立原发性巨细胞病毒眼部感染模型中的宿主免疫应答及相关临床特征

Host Immune Response and Associated Clinical Features in a Primary Cytomegalovirus Eye Infection Model Using Anterior Chamber Inoculation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

研究在大鼠前房接种巨细胞病毒(CMV)以复现免疫健全宿主眼前段感染,并评估更昔洛韦与糖皮质激素的效果。结果显示眼内压升高与眼部浸润和炎症高度相关,早期更昔洛韦增强T细胞相关细胞因子释放并促进引流淋巴结NKT和T细胞募集,糖皮质激素单用或联用虽降低眼内压升高但阻碍病毒DNA清除。

要点

  • 大鼠前房接种CMV可复现人CMV眼前段感染的典型病理特征。
  • 眼内压升高与眼部浸润和炎症高度相关。
  • 糖皮质激素单用或联用更昔洛韦降低眼内压升高但阻碍DNA清除。

核心结论

  • 前房接种模型复现了人CMV眼前段感染的典型病理特征。
  • 当前实践中使用糖皮质激素可能阻碍病毒清除,而更昔洛韦治疗可辅助细胞因子表达以对抗病毒。

研究设计与样本

  • 采用前房接种模型在免疫健全大鼠中复现CMV眼前段感染。
  • 通过流式细胞术、细胞因子分析、组织病理切片和定量聚合酶链反应研究感染后免疫应答。
  • 评估更昔洛韦和糖皮质激素治疗的效果。

主要发现

  • 大鼠前房接种CMV引发人CMV眼前段感染的典型病理特征。
  • 接种后眼前段固有免疫和适应性免疫序贯发展,眼内压升高与眼部浸润和炎症高度相关。
  • 早期眼部免疫应答减少眼前段病毒DNA并减轻病毒性淋巴结病。
  • 早期更昔洛韦干预增强T应答相关细胞因子释放并促进引流淋巴结中NKT和T细胞募集。
  • 糖皮质激素单用或联用更昔洛韦降低眼内压升高但阻碍DNA清除。

临床怎么用

  • 作者认为当前实践中使用糖皮质激素可能阻碍病毒清除。
  • 作者认为更昔洛韦治疗可辅助细胞因子表达以对抗病毒。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the pathogenesis of cytomegalovirus (CMV)-associated anterior segment infection in immunocompetent hosts and evaluate the effects of ganciclovir and glucocorticoid treatment in management of the disease. METHODS: We used an inoculation model to reproduce CMV anterior segment infection in immunocompetent rats. Flow cytometry, cytokine analysis, histopathological sections, and quantitative polymerase chain reaction were performed to investigate the immune response after CMV infection. The effects of ganciclovir and glucocorticoid treatment were also assessed. RESULTS: Anterior chamber inoculation of CMV in rats provoked characteristic pathological features of human CMV anterior segment infection. The innate and adaptive immunity sequentially developed in an anterior segment after inoculation, and the elevation of intraocular pressure (IOP) was highly associated with ocular infiltration and inflammation. Early ocular immune response reduced virus DNA in the anterior segment and alleviated viral lymphadenopathy. Early intervention with ganciclovir enhanced the release of cytokines associated with T response and facilitated recruitment of NKT and T cells in drainage lymph nodes. Glucocorticoid treatment, alone or combined with ganciclovir, decreased elevation of IOP but also impeded DNA clearance. CONCLUSIONS: The inoculation model reproduced characteristic pathological features of human CMV anterior segment infection. The use of glucocorticoid in current practice may hinder viral clearance, and ganciclovir therapy can assist cytokine expression to combat the virus.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Su CC, Gao CM, Peng FT, et al. Host Immune Response and Associated Clinical Features in a Primary Cytomegalovirus Eye Infection Model Using Anterior Chamber Inoculation. Invest Ophthalmol Vis Sci. 2022. PMID: 35579904. doi:10.1167/iovs.63.5.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。